Recall Z-0349-2023

Primus Corporation dba Trinity Biotech · initiated October 5, 2021

Class III Terminated

Class III – products unlikely to cause any adverse health reaction but that violate FDA labeling or manufacturing laws

Product

A. MENARINI diagnostics Hb 9210 PREMIER, LEVEL1, LEVEL II, Hemoglobin A1c Controls for hemoglobin A1c Assay, REF 45052, part number 05-01-0926, A1c analysis

Codes / lots: Lot 12161

Reason for recall

The Control Level I material value was showing results exceeding the upper limit of the acceptable range after a period of three (3) months. The unacceptable Control Level 1 value results in the Analyzer generating an error code which stops further testing and nullifies associated patient samples, resulting in a delay in patient results and a potential delay in therapeutic modifications.

FDA-determined cause: Nonconforming Material/Component

Action taken

The firm sent an Urgent Filed Safety Notice their consignees on 10/05/2021 by mail. The notice explained the issue, risk and requested the destruction of of the affected devices.

Details

Recall number
Z-0349-2023
Initiated
October 5, 2021
Posted by FDA
December 1, 2022
Terminated
August 9, 2023
Product code
JPK – Mixture, Hematology Quality Control
Quantity
340 kits
Distribution
Turkey, India, Romania, Thailand, Vietnam, S. Korea, Peru, Pakistan Austria, UAE, Chile, Italy.
Recalling firm
Primus Corporation dba Trinity Biotech, Kansas City, MO

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-0350-2023 Class IIITrinity Biotech HbA1c (GHb) Contorls Kit, 500uL (Levels I & II), REF 01-04-0020, Part…The Control Level I material value was showing results exceeding the upper limit of the acceptable range… 10/05/2021Terminated